0.00EUR
902.00 KEUR
13.71 MEUR
159.56 M
About VISIOMED GROUP
Sector
Industry
CEO
Clement Pacaud
Website
Headquarters
Paris
Employees (FY)
94
Founded
2009
ISIN
FR0013481835
FIGI
BBG00LG7BJL3
Visiomed Group SA engages in the development and distribution of healthcare products and services. It operates through the Connected Health, Digitalized Medical Centers, and Other Medical Products and Services segments. The Connected Health segment refers to the strategic activity of the firm which includes telemedicine. The Digitalized Medical Centers segment includes the digitalization of patients' journey that allows taking samples using robotics and connected medical devices and delivering of results using artificial intelligence. The Other Medical Products and Services segment covers historical residual activities of the group and the sales of personal protective and testing equipment. The company was founded by Eric Sebban in June 2007 and is headquartered in Paris, France.
An aggregate view of professional's ratings.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 7V91 is 0.18 EUR — it has decreased by 6.32% in the past 24 hours. Watch VISIOMED GROUP SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange VISIOMED GROUP SA stocks are traded under the ticker 7V91.
7V91 stock has risen by 7.63% compared to the previous week, the month change is a 11.44% fall, over the last year VISIOMED GROUP SA has showed a 65.10% decrease.
We've gathered analysts' opinions on VISIOMED GROUP SA future price: according to them, 7V91 price has a max estimate of 0.70 EUR and a min estimate of 0.70 EUR. Watch 7V91 chart and read a more detailed VISIOMED GROUP SA stock forecast: see what analysts think of VISIOMED GROUP SA and suggest that you do with its stocks.
7V91 reached its all-time high on Jun 13, 2023 with the price of 0.55 EUR, and its all-time low was 0.09 EUR and was reached on Dec 21, 2021. View more price dynamics on 7V91 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
7V91 stock is 6.74% volatile and has beta coefficient of 1.16. Track VISIOMED GROUP SA stock price on the chart and check out the list of the most volatile stocks — is VISIOMED GROUP SA there?
Today VISIOMED GROUP SA has the market capitalization of 57.29 M, it has increased by 12.15% over the last week.
Yes, you can track VISIOMED GROUP SA financials in yearly and quarterly reports right on TradingView.
7V91 net income for the last half-year is 1.58 M EUR, while the previous report showed −675.00 K EUR of net income which accounts for 333.63% change. Track more VISIOMED GROUP SA financial stats to get the full picture.
No, 7V91 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 29, 2024, the company has 94.00 employees. See our rating of the largest employees — is VISIOMED GROUP SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VISIOMED GROUP SA EBITDA is 1.10 M EUR, and current EBITDA margin is 9.05%. See more stats in VISIOMED GROUP SA financial statements.
Like other stocks, 7V91 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VISIOMED GROUP SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VISIOMED GROUP SA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VISIOMED GROUP SA stock shows the sell signal. See more of VISIOMED GROUP SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.